Searchable abstracts of presentations at key conferences in endocrinology

ea0006s3biog | Society for Endocrinology Medal Lecture | SFE2003

Society for Endocrinology Medal Lecture

Lowry P

Phil Lowry, School of Animal and Microbial Sciences, University of Reading, Reading, UK AbstractProfessor Phil Lowry is best known for his research on pituitary hormones, corticotrophin-releasing factor (CRF) and the involvement of neuropeptides in pre-eclampsia. A peptide biochemist by training, his preparations of purified corticotrophin (ACTH) and growth hormone (GH) became standards of the World Health Organisation...

ea0078dmd1.3 | Symposium 1 | BSPED2021

Personalising insulin therapy using smart pumps, pens and automated insulin delivery systems

Mader Julia K.

People living with diabetes face the daily burden of managing their disease. The ongoing challenge of administering insulin, testing heir glucose and adhering to recommended lifestyle can be overwhelming. Diabetes technology can alleviate some of this burden. However, the technology should be chosen wisely upon preferences and competences of affected people. Insulin pump use has been increasing over the last decades. Insulin pumps re considered a comfortable way to deliver ins...

ea0083cbp6 | Calcium and Bone | EYES2022

Hyperemesis gravidarum as a clinical presentation of primary hyperparathyrioidism

M. Lekin , I. Bajkin , T. Icin , K. Stepanovic , M. Manojlovic

Background: Hyperemesis gravidarum is a rare condition with multiple causes. Diagnosis is based on clinical examination and measurement of urine ketones, serum electrolytes, and renal function. Hyperparathyroidism during pregnancy can rarely be manifested with clinical presentation of hyperemesis gravidarum with substantial maternal and fetal complications. In most cases adequate hydration, with or without forced diuresis, as well as with low calcium content diet is treatment ...

ea0090s5.3 | Prolactinomas | ECE2023

Alternative medical treatments for prolactinomas

Auriemma Renata Simona

Dopamine agonists (DA), mainly cabergoline, are nowadays recommended as the treatment of choice for patients with prolactinomas of any size to lower PRL levels, decrease tumour size, and restore gonadal function. However, some patients do not adequately respond to DA, and resistance to DA may occur in 20-30% of patients treated with bromocriptine and nearly 10-20% of those receiving cabergoline. In these patients, multimodal therapy, including surgery and/or radiotherapy, may ...

ea0065p80 | Bone and calcium | SFEBES2019

Assessing the use of Cinacalcet for conservative management of primary hyperparathyroidism in a regional district general hospital

Kelly Neil Patrick , Santhakumar Anjali

Background: The treatment of choice for symptomatic primary hyperparathyroidism (PHPT) is surgery, however in many cases patient choice or medical comorbidities preclude this treatment modality.Aim: This audit examines the use of cinacalcet in management of primary hyperparathyroidism in a district general hospital to determine if it is in accordance with the National institute for health and care excellence (NICE) guidance (May 2019).<p class="abste...

ea0065p335 | Nursing practice | SFEBES2019

The role of microbiological cultures in managing diabetic foot osteomyelitis

Madani Devangi , Tiwari Alok , David Miruna , Saeed Mujahid

Background and aims: Diabetic foot osteomyelitis (DFO) is a well-recognised complication and a risk factor for lower limb loss. Its effective treatment can reduce the risk of minor and major amputations. Our aim was to compare the yield in cultures from the proximal and distal segments of bone excised intraoperatively as part of the management of DFO and the impact on antibiotic choice and duration.Materials and methods: Patients attending the diabetic f...

ea0063s24.3 | What's new in the Adrenal Cortex? (Endorsed by the European Journal of Endocrinology) | ECE2019

Autonomous cortisol secretion has cardiovascular consequences

Chiodini Prof Iacopo

Background: Patients with adrenal incidentaloma (AI) and autonomous cortisol secretion (ACS) show a high prevalence of cardiovascular risk factors and an increased prevalence and incidence of cardiovascular events. Furthermore, some recent data suggest that in these patients, the cardiovascular mortality is also increased. Unfortunately, to date, the diagnosis of ACS is still a matter of debate, and, therefore, it is still not possible to reliably predict the effect of the rec...

ea0041ep856 | Pituitary - Basic | ECE2016

Selection and validation of reliable reference genes for RT-qPCR analysis in a large cohort of pituitary adenomas

Normann Kjersti R , Oystese Kristin Astrid Berland , Berg Jens Petter , Bollerslev Jens , Olarescu Nicoleta Cristina

Background: Real-time reverse transcription quantitative PCR (RT-qPCR) has become the method of choice for quantification of gene expression changes. Inappropriate data normalization and inconsistent data analyses are some limitations of RT-qPCR. Pituitary adenomas are frequent tumours and the interpretation of increasingly published data within this field is hindered by the lack of a proper selection and validation of stably expressed reference genes.Ai...

ea0038s11.2 | Epigenetics in endocrine-related cancers (Supported by <emphasis role="italic">Endocrine-Related Cancer</emphasis>) | SFEBES2015

Epigenetic regulation of androgen receptor function in prostate cancer

Campbell Moray

The androgen receptor (AR) is a major therapeutic target once prostate cancer has progressed. Even invasive cells remain initially responsive to androgen deprivation therapy (ADT) but ultimately become ADT-recurrent, which is lethal. Aggressive ADT-recurrent cells nonetheless retain active AR signaling, but in a distorted form as a result of the actions of transcription factor co-regulators, including the corepressors, for example as revealed by the TCGA consortium. We have ex...

ea0037s12.2 | Advances in phaeochromocytoma diagnosis and management (<emphasis role="italic">Endorsed by the European Journal of Endocrinology</emphasis>) | ECE2015

Current imaging of pheochromocytoma/paraganglioma

Timmers Henri

After establishing a biochemical diagnosis, pheochromocytomas and paragangliomas can be localized using different imaging modalities. Appropriate imaging is critical for primary tumor localization, the detection of multiple primary tumors and the detection of metastases. This will guide the optimal choice between curative surgery and palliative treatment options.First line anatomical imaging modalities for pheochromocytoma and paraganglioma imaging inclu...